副次性副甲状腺機能障害. 副次性副甲状腺機能障害. 副次性副甲状腺機能障害. 腎不全患者の保守的な管理

M M Popovtzer, W F Pinggera, J B Robinette

JAMA

|March 3, 1975

まとめ

リン酸結合抗酸剤とカルシウム炭酸は,進行性腎疾患の患者で二次性パラチロイド症を効果的に管理しました. この治療は副甲状腺ホルモンのレベルを正常化し,関連する症状や骨疾患を緩和しました.

科学分野:

ネフロロジーはネフロロジーを用います.
エンドクリノロジーエンドクリノロジー
ミネラルメタボリズム

背景:

進行した腎臓病は,しばしば二次性パラチロイド性多発症につながる.
システミックな症状には,骨疾患やホルモンの不均衡が含まれます.

研究の目的:

フォスファート結合剤と経口カルシウム炭酸の二次性副甲状腺症の管理における有効性を評価する.
血清カルシウム,リン,副甲状腺ホルモン,および臨床症状への影響を評価する.

主な方法:

進行性腎疾患 (インスリンのクリアランス4.6-9.1ml/min) の3人の患者の治療.
リン酸結合抗酸剤と経口カルシウム炭酸塩の投与.
血清カルシウム,リン,および免疫反応性副甲状腺ホルモンのレベルをモニタリングする.

主要な成果:

血清カルシウムとリン濃度は正常な範囲で維持されました.
二次性パラチロイド症の症状の漸進的な消失.
繊維性骨炎の治癒が観察されました.
血清の免疫反応性副甲状腺ホルモン濃度の正常化.

結論:

リン酸結合抗酸剤と経口カルシウム炭酸は,進行性腎臓疾患における二次性副甲状腺症の管理に有効です.
この治療的アプローチは,症状の解消と生化学的正常化につながる可能性があります.
繊維性骨炎の治療に成功したことが実証されました.

さらに関連する動画

04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

関連する概念動画

01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...

01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

関連する実験動画